First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain

Boshi Huang; Xinhao Liu; Ye Tian; Dongwei Kang; Zhongxia Zhou; Dirk Daelemans; De Clercq Erik; Christophe Pannecouque; Peng Zhan; Xinyong Liu

doi:10.1016/j.bmcl.2018.03.012

Back

Shared by

De Clercq Erik

KU Leuven

First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain

Article 2018 en

Authors

BH
Boshi Huang
XL
Xinhao Liu
YT
Ye Tian

Related publications

Article2021

Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses

Zhipeng Fu, Tao Zhang, Zhongxia Zhou, Dongwei Kang, Lin Sun, Shenghua Gao, Srinivasulu Cherukupalli, De Clercq Erik, Christophe Pannecouque, Xinyong Liu, Peng Zhan

Letter2019

Molecular and cellular studies evaluating a potent 2-cyanoindolizine catechol diether NNRTI targeting wildtype and Y181C mutant HIV-1 reverse transcriptase

Tomoaki Sasaki, Zira T. K. Gannam, Shalley N. Kudalkar, Kathleen M. Frey, Won‐Gil Lee, Krasimir A. Spasov, William L. Jorgensen, Karen S. Anderson

Bioorganic & Medicinal Chemistry Letters

Article2003

Activity predictions for efavirenz analogues with the K103N mutant of HIV reverse transcriptase

Marina Udier–Blagović, Edward K. Watkins, Julian Tirado‐Rives, William L. Jorgensen

Bioorganic & Medicinal Chemistry Letters

Article2009

Discovery of Wild-Type and Y181C Mutant Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors Using Virtual Screening with Multiple Protein Structures

Sara E. Nichols, Robert A. Domaoal, Vinay V. Thakur, Julian Tirado‐Rives, Karen S. Anderson, William L. Jorgensen

Journal of Chemical Information and Modeling

Article2019

Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus

Zhongxia Zhou, Tao Liu, Gaochan Wu, Dongwei Kang, Zhipeng Fu, Zhao Wang, De Clercq Erik, Christophe Pannecouque, Peng Zhan, Xinyong Liu

First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain

Discussion(0)

Related publications

Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses

Molecular and cellular studies evaluating a potent 2-cyanoindolizine catechol diether NNRTI targeting wildtype and Y181C mutant HIV-1 reverse transcriptase

Activity predictions for efavirenz analogues with the K103N mutant of HIV reverse transcriptase

Discovery of Wild-Type and Y181C Mutant Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors Using Virtual Screening with Multiple Protein Structures

Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus